Unidad Mixta CIPF-UPV de Mecanismos de Enfermedades y Nanomedicina Spain

Research

Date range: 1 August 2022 - 31 July 2023

Region: Global
Subject/journal group: All

The table to the right includes counts of all research outputs for Unidad Mixta CIPF-UPV de Mecanismos de Enfermedades y Nanomedicina published between 1 August 2022 - 31 July 2023 which are tracked by the Nature Index.

Hover over the donut graph to view the Share for each subject. Below, the same research outputs are grouped by subject. Click on the subject to drill-down into a list of articles organized by journal, and then by title.

Note: Articles may be assigned to more than one subject area.

Article Count and Share for Unidad Mixta CIPF-UPV de Mecanismos de Enfermedades y Nanomedicina
Count Share
3 0.28

Outputs by subject (Share)

Outputs by subject
Subject Count Share
1 0.01
2 0.26
1 0.01

Share output for the past 5 years

Share per year
2018 2019 2020 2021 2022*
0.00 0.60 0.58 0.41 0.15

Compare Unidad Mixta CIPF-UPV de Mecanismos de Enfermedades y Nanomedicina with other institutions

*Note: 2022 data contains Share for article affiliations from newly added health-science journals.

Nature Strategy Reports

Nature Strategy Reports gives you simple insights to support decisions that impact your organisation

The reports created for you by our subject matter experts combine compelling insights with Nature’s trust and authority. Get an in-depth analysis of your and your peers’ research performance, including a breakdown of relative strengths and weaknesses. All of which is crafted using data and tools from across Nature Research Intelligence, covering all major disciplines and all regions of the world.

Collaboration

Date range: 1 August 2022 - 31 July 2023

International vs. domestic collaboration by Share

  • 92.26% Domestic (24 institutions)
  • 7.74% International (10 institutions)

Hover over the graph to view the percentage of collaboration.


Top 10 domestic collaborators with Unidad Mixta CIPF-UPV de Mecanismos de Enfermedades y Nanomedicina by Share*

  1. Unidad Mixta CIPF-UPV de Mecanismos de Enfermedades y Nanomedicina and Institute of Health Carlos III (ISCIII) (0.87)
    Unidad Mixta CIPF-UPV de Mecanismos de Enfermedades y Nanomedicina0.28
    Institute of Health Carlos III (ISCIII)0.60
  2. Unidad Mixta CIPF-UPV de Mecanismos de Enfermedades y Nanomedicina and Polytechnic University of Valencia (UPV) (0.85)
    Unidad Mixta CIPF-UPV de Mecanismos de Enfermedades y Nanomedicina0.28
    Polytechnic University of Valencia (UPV)0.57
  3. Unidad Mixta CIPF-UPV de Mecanismos de Enfermedades y Nanomedicina and Institute of Molecular Recognition and Technological Development (IDM) (0.83)
    Unidad Mixta CIPF-UPV de Mecanismos de Enfermedades y Nanomedicina0.28
    Institute of Molecular Recognition and Technological Development (IDM)0.55
  4. Unidad Mixta CIPF-UPV de Mecanismos de Enfermedades y Nanomedicina and Joint Research Unit in Nanomedicine and Sensors (0.58)
    Unidad Mixta CIPF-UPV de Mecanismos de Enfermedades y Nanomedicina0.26
    Joint Research Unit in Nanomedicine and Sensors0.32
  5. Unidad Mixta CIPF-UPV de Mecanismos de Enfermedades y Nanomedicina and University of Valencia (UV) (0.58)
    Unidad Mixta CIPF-UPV de Mecanismos de Enfermedades y Nanomedicina0.28
    University of Valencia (UV)0.30
  6. Unidad Mixta CIPF-UPV de Mecanismos de Enfermedades y Nanomedicina and Centro de Investigación Príncipe Felipe (CIPF) (0.51)
    Unidad Mixta CIPF-UPV de Mecanismos de Enfermedades y Nanomedicina0.28
    Centro de Investigación Príncipe Felipe (CIPF)0.24
  7. Unidad Mixta CIPF-UPV de Mecanismos de Enfermedades y Nanomedicina and La Fe University Hospital (0.42)
    Unidad Mixta CIPF-UPV de Mecanismos de Enfermedades y Nanomedicina0.26
    La Fe University Hospital0.16
  8. Unidad Mixta CIPF-UPV de Mecanismos de Enfermedades y Nanomedicina and Barcelona Institute of Science and Technology (BIST) (0.33)
    Unidad Mixta CIPF-UPV de Mecanismos de Enfermedades y Nanomedicina0.08
    Barcelona Institute of Science and Technology (BIST)0.25
  9. Unidad Mixta CIPF-UPV de Mecanismos de Enfermedades y Nanomedicina and Catalan Institution for Research and Advanced Studies (ICREA) (0.17)
    Unidad Mixta CIPF-UPV de Mecanismos de Enfermedades y Nanomedicina0.08
    Catalan Institution for Research and Advanced Studies (ICREA)0.08
  10. Unidad Mixta CIPF-UPV de Mecanismos de Enfermedades y Nanomedicina and Spanish National Cancer Research Centre (CNIO) (0.12)
    Unidad Mixta CIPF-UPV de Mecanismos de Enfermedades y Nanomedicina
    Spanish National Cancer Research Centre (CNIO)0.11

Top 10 international collaborators with Unidad Mixta CIPF-UPV de Mecanismos de Enfermedades y Nanomedicina by Share*

  1. Unidad Mixta CIPF-UPV de Mecanismos de Enfermedades y Nanomedicina and Amsterdam UMC (0.08)
    Unidad Mixta CIPF-UPV de Mecanismos de Enfermedades y Nanomedicina
    Amsterdam UMC
  2. Unidad Mixta CIPF-UPV de Mecanismos de Enfermedades y Nanomedicina and University of Graz (Uni Graz) (0.08)
    Unidad Mixta CIPF-UPV de Mecanismos de Enfermedades y Nanomedicina
    University of Graz (Uni Graz)
  3. Unidad Mixta CIPF-UPV de Mecanismos de Enfermedades y Nanomedicina and Ohio University (Ohio) (0.05)
    Unidad Mixta CIPF-UPV de Mecanismos de Enfermedades y Nanomedicina
    Ohio University (Ohio)
  4. Unidad Mixta CIPF-UPV de Mecanismos de Enfermedades y Nanomedicina and BioTechMed-Graz (0.05)
    Unidad Mixta CIPF-UPV de Mecanismos de Enfermedades y Nanomedicina
    BioTechMed-Graz
  5. Unidad Mixta CIPF-UPV de Mecanismos de Enfermedades y Nanomedicina and Joanneum Research Forschungsgesellschaft mbH (0.05)
    Unidad Mixta CIPF-UPV de Mecanismos de Enfermedades y Nanomedicina
    Joanneum Research Forschungsgesellschaft mbH
  6. Unidad Mixta CIPF-UPV de Mecanismos de Enfermedades y Nanomedicina and NAWI Graz (0.05)
    Unidad Mixta CIPF-UPV de Mecanismos de Enfermedades y Nanomedicina
    NAWI Graz
  7. Unidad Mixta CIPF-UPV de Mecanismos de Enfermedades y Nanomedicina and University of Amsterdam (UvA) (0.05)
    Unidad Mixta CIPF-UPV de Mecanismos de Enfermedades y Nanomedicina
    University of Amsterdam (UvA)
  8. Unidad Mixta CIPF-UPV de Mecanismos de Enfermedades y Nanomedicina and VU Amsterdam (0.05)
    Unidad Mixta CIPF-UPV de Mecanismos de Enfermedades y Nanomedicina
    VU Amsterdam
  9. Unidad Mixta CIPF-UPV de Mecanismos de Enfermedades y Nanomedicina and Graz University of Technology (TU Graz) (0.04)
    Unidad Mixta CIPF-UPV de Mecanismos de Enfermedades y Nanomedicina
    Graz University of Technology (TU Graz)
  10. Unidad Mixta CIPF-UPV de Mecanismos de Enfermedades y Nanomedicina and Medical University of Graz (Med Uni Graz) (0.02)
    Unidad Mixta CIPF-UPV de Mecanismos de Enfermedades y Nanomedicina
    Medical University of Graz (Med Uni Graz)

*Share is the fractional count allocated to an institution for an article that takes into account the percentage of authors from that institution and the number of affiliated institutions that contributed to the article. The horizontal stacked bar charts above indicate the Share contributed by each institution in the bilateral collaboration. If the Share is not shown, hover over the bar to display it.

Nature Careers

Need to hire scientific researchers?

Nature Careers is visited by over 180,000 active jobseekers per month that you can target directly with your role. Application response rates have increased by 28% on average over 2022 averages.

Relationships

Partner Institutions

Unidad Mixta CIPF-UPV de Mecanismos de Enfermedades y Nanomedicina is a research collaboration whose article contributions are accrued to its participating partner institutions below.